Study of clinical profile of Guillain-Barré syndrome in children upto 12 years during an epidemic outbreak
DOI:
https://doi.org/10.18203/2349-3291.ijcp20252606Keywords:
GBS, IVIG, Nerve conduction velocity study, AFPAbstract
Guillain-Barré syndrome (GBS) is an acute inflammatory polyneuropathy and leading cause of Acute flaccid paralysis (AFP) in children. Outbreaks are often linked to infections, but regional data on paediatric GBS in India remains limited. To describe the clinical presentation of paediatric GBS cases admitted in RCSM GMC Kolhapur during an outbreak that occurred in Maharashtra, India in 2025. To correlate electrophysiological findings with clinical profile and outcomes of paediatric GBS cases admitted in RCSM GMC Kolhapur during an outbreak that occurred in Maharashtra, India in 2025. This is a descriptive observational case series of 5 children admitted with GBS during an outbreak. Cases were diagnosed using Brighton Collaboration criteria and nerve conduction velocity (NCV) studies. Clinical features, antecedent infections, CSF (Cerebrospinal fluid) analysis, and treatment responses were recorded. Samples were tested at the National Institute of Virology (NIV), Pune. Outcomes were assessed using the Hughes Functional Grading Scale. Five cases (3 male, 2 female) showed variable severity, with antecedent infections in four. NCV revealed AIDP (4 cases) and AMAN (1 case). Two patients required ventilation, one developed bradycardia, another ventilator-associated pneumonia. Intravenous Immunoglobulin (IVIG) (2 g/kg) was effective, with three achieving full recovery and two having residual weakness. Campylobacter jejuni was detected in one case. Paediatric GBS during outbreaks presents with diverse severity but responds well to IVIG. Early diagnosis and monitoring of respiratory/cranial involvement are crucial. Strengthening surveillance and investigating infectious triggers is recommended.
Metrics
References
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388:717-27. DOI: https://doi.org/10.1016/S0140-6736(16)00339-1
Kalra V, Chaudhry R, Dua T, Dhawan B, Sahu JK, Mridula B. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study. J Child Neurol. 2009;24(6):664-8. DOI: https://doi.org/10.1177/0883073808325649
Verma R, Chaudhari TS, Raut TP, Garg RK. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barré syndrome in children. J Pediatr Neurosc. 2013;8(2):94-8. DOI: https://doi.org/10.1016/j.jns.2013.09.002
Sharma CM, Kumawat BL, Ralot T, Tripathi G, Dixit S. Guillain-Barre syndrome occurring during dengue fever. J Indian Med Assoc. 2011;109(9):675-82.
Pari H, Amalnath SD, Dhodapkar R. Guillain-Barre Syndrome and Antibodies to Arboviruses (Dengue, Chikungunya, and Japanese Encephalitis) in Southern India. Ann Indian Acad Neurol. 2022;25(2):203-6. DOI: https://doi.org/10.4103/aian.aian_589_21
Dutta D, Debnath M, Nagappa M, Das SK, Wahatule R, Sinha S, et al. Antecedent infections in Guillain-Barré syndrome patients from south India. J Peripher Nerv Syst. 2021;26(3):298-306. DOI: https://doi.org/10.1111/jns.12459
Shrivastava M, Nehal S, Seema N. Guillain-Barre syndrome: Demographics, clinical profile & seasonal variation in a tertiary care centre of central India. Indian J Med Res. 2017;145(2):203-8. DOI: https://doi.org/10.4103/ijmr.IJMR_995_14
Roodbol J, Wit MY, Berg B, Kahlmann V, Drenthen J, Catsman-Berrevoets CE, et al. Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria. J Neurol. 2017;264(5):856-61. DOI: https://doi.org/10.1007/s00415-017-8429-8
Monique M. Ryan. Guillain-Barre syndrome. In:Kliegman RM, St. Geme JW III,editors. Nelson Textbook of Pediatrics. 22nd ed. Elsevier; 2024. Chapter 656:3900-6.
Kalita J, Misra UK, Das M. A study of clinical, electrophysiological and prognostic profiles of Guillain-Barré syndrome. Acta Neurol Scand. 2004;110(2):106-13.